WebBiological Activity. GB1107 (GB-1107, GB 1107) is a potent, selective, orally active inhibitor of Galectin-3 (Gal-3) with Kd of 37 nM (human Galectin-3). GB1107 displays >100-fold lower affinity for most of the tested human galectins, and 20 and 4-fold lower affinity for galectin-2 and the C-terminal CRD of galectin-4, respectively. WebMay 30, 2024 · Inhibitor combination studies show enzalutamide (ENZ), 2-phosphonomethyl pentanedioic acid (2-PMPA), and GB1107 as highly cytotoxic for LNCaP and LNCaP-KD cells, while Docetaxel (DOC) + GB1107 show greater efficacy in PC-3 cells. Overall, 2-PMPA and GB1107 demonstrate synergistic cytotoxic effects with ENZ and DOC in …
Galectin-3 has a key role in Gastric Cancer
WebA reduction in IL-1, IL-6 and TNF-α levels upon treatment with the Gal-3 inhibitor GB1107 was also seen in an inflammatory model of spinal cord injury (Ren et al., 2024). … WebSep 11, 2016 · GB1107 (10mg/kg) significantly reduced the fibrosis score. and decreased the number of macrophages and collagen concentration in the BAL fluid with decreased surface expression of galectin-3 on BAL macrophages. GB1211 at 20 mg/kg twice daily reduced collagen accumulation by 36%. dragon ball z tenkaichi tag team rom
Frontiers An Evaluation of the Mechanisms of Galacto …
WebProduct Name. Target. Research Areas. HY-114409. GB1107. Galectin. Cancer. GB1107 is a potent, selective, orally active inhibitor of Galectin-3 (Gal-3) with a Kd of 37 nM for human Galectin-3. GB1107 reduces human and mouse lung adenocarcinoma growth and blocks metastasis in the syngeneic model. WebAbstract. Small-molecule galectin inhibitors are useful research tools that could also be used as potential drug candidates. In that context, GB1107, a monosaccharidic galectin … WebAbstract. Small-molecule galectin inhibitors are useful research tools that could also be used as potential drug candidates. In that context, GB1107, a monosaccharidic galectin inhibitor, was shown to be an orally active galectin-3 antagonist that inhibits lung adenocarcinoma growth. Herein, a protecting-group-free synthesis of GB1107, along ... emily staveley-taylor